Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3849931017 | Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3849933019 | Insulin lispro protamine- and insulin lispro-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) | Is a | Product containing insulin lispro and insulin lispro protamine (medicinal product) | true | Inferred relationship | Some | ||
| Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) | Is a | Insulin lispro-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) | Has active ingredient | Insulin lispro | true | Inferred relationship | Some | 1 | |
| Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) | Has active ingredient | Insulin lispro protamine (substance) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) | Is a | False | Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) | Is a | False | Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing only insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) | Is a | True | Product containing insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
FHIR